YESAFILI 40 MG/ML SOL INJ IVI T CT 1FA VD TRANS X 0,278ML + AGU + SER
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1166400110029 -
GGREM
650726090003207 -
Código de barras
8905056005066
O que a fonte publica
- Detentor do registro
- BIOCON BIOLOGICS DO BRASIL LTDA
- Princípios ativos
- AFLIBERCEPTE
- Embalagem
- 40 MG/ML SOL INJ IVI T CT 1FA VD TRANS X 0,278ML + AGU + SER
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- S1P - PRODUTOS ANTINEOVASCULARIZAÇÃO OCULAR
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "YESAFILI 40 MG/ML SOL INJ IVI T CT 1FA VD TRANS X 0,278ML + AGU + SER",
"holder": "BIOCON BIOLOGICS DO BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"8905056005066"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "650726090003207",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "38.108.988/0001-80",
"priceRegime": "Regulado",
"productName": "YESAFILI",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "40 MG/ML SOL INJ IVI T CT 1FA VD TRANS X 0,278ML + AGU + SER",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "3637.46",
"icms-12": "4133.48",
"icms-17": "4382.48",
"icms-18": "4435.93",
"icms-19": "4490.69",
"icms-20": "4546.83",
"icms-21": "4604.38",
"icms-22": "4663.41",
"icms-23": "4723.97",
"icms-17.5": "4409.04",
"icms-19.5": "4518.58",
"icms-20.5": "4575.42",
"icms-22.5": "4693.50",
"icms-12-alc": "4083.87",
"icms-17-alc": "4329.89",
"icms-18-alc": "4382.70",
"icms-19-alc": "4436.80",
"icms-20-alc": "4492.26",
"icms-21-alc": "4549.13",
"icms-22-alc": "4607.45",
"icms-23-alc": "4667.28",
"withoutTaxes": "3593.81",
"icms-17.5-alc": "4356.13",
"icms-19.5-alc": "4464.36",
"icms-20.5-alc": "4520.52",
"icms-22.5-alc": "4637.18"
},
"pisCofinsList": "Positiva",
"substanceText": "AFLIBERCEPTE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "5013.86",
"icms-12": "5697.57",
"icms-17": "6040.79",
"icms-18": "6114.47",
"icms-19": "6189.95",
"icms-20": "6267.33",
"icms-21": "6346.66",
"icms-22": "6428.02",
"icms-23": "6511.50",
"icms-17.5": "6077.40",
"icms-19.5": "6228.39",
"icms-20.5": "6306.74",
"icms-22.5": "6469.50",
"icms-12-alc": "5645.71",
"icms-17-alc": "5985.82",
"icms-18-alc": "6058.83",
"icms-19-alc": "6133.62",
"icms-20-alc": "6210.29",
"icms-21-alc": "6288.91",
"icms-22-alc": "6369.53",
"icms-23-alc": "6452.24",
"withoutTaxes": "4968.23",
"icms-17.5-alc": "6022.09",
"icms-19.5-alc": "6171.72",
"icms-20.5-alc": "6249.35",
"icms-22.5-alc": "6410.63"
},
"invalidBarcodes": [],
"activeSubstances": [
"AFLIBERCEPTE"
],
"therapeuticClass": "S1P - PRODUTOS ANTINEOVASCULARIZAÇÃO OCULAR",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1166400110029",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "S1P",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:650726090003207"